Singapore markets closed

Adhera Therapeutics, Inc. (ATRX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00600.0000 (0.00%)
As of 03:56PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 43.33k
Enterprise value 10.84M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.23
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA -8.40

Trading information

Stock price history

Beta (5Y monthly) -0.10
52-week change 3-98.33%
S&P500 52-week change 321.23%
52-week high 30.6000
52-week low 30.0060
50-day moving average 30.0116
200-day moving average 30.0222

Share statistics

Avg vol (3-month) 3108.4k
Avg vol (10-day) 358.97k
Shares outstanding 57.22M
Implied shares outstanding 67.22M
Float 86.67M
% held by insiders 111.67%
% held by institutions 10.00%
Shares short (31 Jan 2012) 42.05k
Short ratio (31 Jan 2012) 43.24
Short % of float (31 Jan 2012) 43.93%
Short % of shares outstanding (31 Jan 2012) 43.92%
Shares short (prior month 30 Nov 2011) 41.99k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 303 Aug 2017
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 306 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-532.88%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-4.61M
Diluted EPS (ttm)-1.1700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)32.39k
Total cash per share (mrq)0
Total debt (mrq)10.83M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.00
Book value per share (mrq)-5.09

Cash flow statement

Operating cash flow (ttm)-714.19k
Levered free cash flow (ttm)563.75k